PubRank

Haidong Cai

Author PubWeight™ 10.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling. J Clin Endocrinol Metab 2013 0.87
2 A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials 2012 0.86
3 Genetic polymorphism of glucokinase on the risk of type 2 diabetes and impaired glucose regulation: evidence based on 298,468 subjects. PLoS One 2013 0.85
4 MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Int J Cancer 2013 0.84
5 miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma. PLoS One 2013 0.84
6 Cytokines as prognstic tool in breast carcinoma. Front Biosci (Landmark Ed) 2011 0.82
7 Inhibiting roles of berberine in gut movement of rodents are related to activation of the endogenous opioid system. Phytother Res 2013 0.81
8 Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats. Cell Biochem Funct 2012 0.80
9 Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles. Mol Pharm 2012 0.79
10 Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo. Biochem Biophys Res Commun 2012 0.78
11 A cross-linked polymeric micellar delivery system for cisplatin(IV) complex. Eur J Pharm Biopharm 2012 0.76
12 Experimental study of 99mTc-depreotide preparation and its affinity with A549 cell. Front Biosci (Landmark Ed) 2011 0.76
13 Therapeutic effect of 188Re-MAG3-depreotide on non-small cell lung cancer in vivo and in vitro. Int J Clin Exp Pathol 2013 0.75
14 A comparison and validation of blood-pool imaging and ECG-gated SPET myocardial perfusion imaging to assess left ventricular ejection fraction. Hell J Nucl Med 2011 0.75
15 The effect of thiazolidinediones on bone mineral density in Chinese older patients with type 2 diabetes. J Bone Miner Metab 2009 0.75